Understanding factors affecting eye health in children

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the factors influencing physiological hyperopia in children aged 6-9 years, aiming to understand its role in preventing myopia progression. By establishing a prospective cohort of preschoolers, the study seeks to identify key factors that contribute to the fading of physiological hyperopia and the onset of myopia. The research is particularly focused on the critical stages of childhood development where these changes occur, providing valuable insights into eye health in young populations.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Children aged 6-9 years old, male or female;
2. Good cooperation in examination;
3. Parents cooperate and sign the informed consent form;

Exclusion Criteria:

1. Children with a history of drug allergy;
2. Pediatric patients with heart disease, cranial trauma or epilepsy, Down syndrome, or glaucoma will be excluded from the cohort.

Where it's running

• Beijing Tongren Hospital
  Beijing, Beijing Municipality, China Recruiting

Study contacts

• Study coordinator: Huaying Xu, MD
• Email: xuhuaying99@163.com
• Phone: 18813072901

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using DIMS Glasses to See if Myopia Progression Slows in Kids

  This observational study tests whether wearing DIMS glasses in children and teens with myopia can slow progression, considering factors like outdoor time and family history.

  Recruiting Semmelweis University · Budapest · NCT07698977

• New-generation myopia-control lenses versus an earlier lens for children 6–14

  This test tries whether a new myopia-control lens (MCL1) slows eye growth more than a previous-generation lens (MCL2) in children aged 6 to 14.

  Recruiting Essilor International · Paris · NCT07462897

• Low-dose atropine eye drops to slow myopia in children

  This tests whether nightly 0.025% atropine eye drops slow worsening of myopia in children aged 5 to 10 compared with placebo.

  Recruiting at 2 sites Phase 3 IDB VisionCare SDN BHD · Kuala Lumpur, Cheras and 1 other locations · NCT07329777

• Where children look through their glasses

  This trial tests how children ages 7–14 look through a new spectacle lens design to see which parts of the lens they use during different tasks.

  Recruiting SightGlass Vision, Inc. · Bloomington, Indiana · NCT07229365

• Children wearing spectacle lenses: mobility during everyday activities

  This test checks whether myopia-control spectacle lenses change how children aged 6–12 move and perform everyday mobility tasks compared with regular single-vision glasses.

  Recruiting SightGlass Vision, Inc. · Glendale, Arizona · NCT07229352

• Testing low-dose atropine eye drops to slow down myopia in children

  This study is testing if low-dose atropine eye drops can help slow down worsening eyesight in children aged 6 to 12 who have myopia.

  Recruiting at 25 sites Phase 3 Oupushifang Pharmaceutical Technology Co., Ltd. · Hefei, Anhui and 24 other locations · NCT06708156

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.